Persistence in prescriptions of branded drugs

International Journal of Industrial Organization

Volumn 22, Issue 4, 2004, Pages 523-540

  Richard, Oliver ^a   Van Horn, Larry ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Advertising; Market structure; Monte Carlo; Pharmaceutical drugs

Indexed keywords

COMPUTER SIMULATION; DATA REDUCTION; MARKETING; MONTE CARLO METHODS; PROBABILITY; SALES;

MARKET STRUCTURES; PHARMACEUTICAL DRUGS;

DRUG PRODUCTS;

EID: 1842581588     PISSN: 01677187     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijindorg.2003.10.001     Document Type: Article

References (23)

1. Becker G., Murphy K. A simple theory of advertising as a good or bad. Quarterly Journal of Economics. 108(4):1993;941-964.
2. Berndt E., Bui L., Lucking-Reiley D., Urban G. Information, marketing, and pricing in the U.S. anti-ulcer drug market. American Economic Association, Papers and Proceedings. 85(2):1995;100-105.
3. Berndt E., Bui L., Lucking-Reiley D., Urban G. The roles of marketing, product quality, and price competition in the growth and composition of the U.S. anti-ulcer drug industry. Bresnahan T.F., Gordon R.J. The Economics of New Goods. NBER Studies in Income and Wealth. vol. 58:1997;277-322 University of Chicago Press, Chicago.
4. Berndt E., Pindyck R., Azoulay P. Journal of Industrial Economics. 51(2):2003;243-270.
5. Bond, R., Lean, D., 1977. Sales, promotion, and product differentiation in two prescription drug markets. Staff Report to the Federal Trade Commission.
6. Coscelli A. The importance of doctors' and patients' preferences in the prescription decision. The Journal of Industrial Economics. 48(3):2000;349-369.
7. Givon M., Horsky D. Untangling the effects of purchase reinforcement and advertising carryover. Marketing Science. 9(2):1991;171-187.
8. Gonul F., Carter F., Petrova E., Srinivasan K. Promotion of prescription drugs and its impact on physicians' choice behavior. Journal of Marketing. 65:2001;79-90.
9. Hahn M., Park S., Krishnamurthi L., Zoltners A. Analysis of new product diffusion using a four-segment trial-repeat model. Marketing Science. 13(3):1994;224-247.
10. Hellerstein J. The importance of the physician in the generic trade-name prescription decision. RAND Journal of Economics. 29(1):1998;108-136.
11. King C. Marketing, product differentiation, and competition in the market for anti-ulcer drugs. Working Paper-Harvard Business School. 2000;. No. 01-014.
12. Leone R. Generalizing what is known about temporal aggregation and advertising carryover. Marketing Science. 14(3):1995;G141-G150.
13. Liesenfeld R., Richard J.F. Monte Carlo methods and Bayesian computation: importance sampling. Smelser N.J., Baltes P.B. International Encyclopedia of the Social and Behavioral Sciences. 2001;10000-10004 Elsevier, Oxford.
14. Liesenfeld R., Richard J.F. Univariate and multivariate stochastic volatility models: estimation and diagnostics. Journal of Empirical Finance. 207:2003;1-27.
15. Liesenfeld R., Richard J.F. Estimation of dynamic bivariate mixture models: comments on watanabe (2000). Journal of Business and Economic Statistics. 21(4):2003;570-576. October 2003.
16. Lillien, Gary L., Rao A., Kalish S. Bayesian estimation and control of detailing effort in a repeat purchase diffusion environment. Management Science. 27(5):1981;493-506.
17. Mahajan V., Wind Y., Sharma S. An approach to repeat-purchase diffusion analysis. Proceedings American Marketing Educator's Conference. 1983;422-446 American Marketing Association, Chicago.
18. Pepall L., Norman G., Richards D. Industrial Organization: Contemporary Theory and Practice. 2001;South-Western College Publishing. ISBN: 0324067720.
19. Richard J.F., Zhang W. Efficient high-dimensional Monte-Carlo importance sampling. Working Paper-University of Pittsburgh. 1998.
20. Rizzo J. Advertising and competition in the ethical pharmaceutical industry: the case of antihypertensive drugs. Journal of Law and Economics. 42(1:1):1999;89-116.
21. Scherer F. Pricing, profits, and technological progress in the pharmaceutical industry. Journal of Economic Perspectives. 7(3):1993;97-115.
22. Wazana A. Physicians and the pharmaceutical industry. Is a gift ever just a gift? Journal of the American Medical Association. 283(3):2000;373-380.
23. Wosińska, M., 2002. Just What the Patient Ordered? Direct-to-Consumer Advertising and the Demand for Pharmaceutical Products. Working Paper #02:04-Harvard Business School.